» Authors » Jacobien C Verhave

Jacobien C Verhave

Explore the profile of Jacobien C Verhave including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 1155
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
van Diepen A, Vening W, Ter Meulen R, Verhave J
Perit Dial Int . 2023 May; 43(4):345-347. PMID: 37150965
No abstract available.
2.
Cobussen M, Verhave J, Buijs J, Stassen P
Int Urol Nephrol . 2022 Jul; 55(1):183-190. PMID: 35859220
Background: Sepsis is often accompanied with acute kidney injury (AKI). The incidence of AKI in patients visiting the emergency department (ED) with sepsis according to the new SOFA criteria is...
3.
Bruinen A, Verhave J, Schouten I
Ned Tijdschr Geneeskd . 2022 May; 166. PMID: 35499767
Graves' orbitopathy may cause multiple symptoms, such as proptosis, redness or inflammation of the conjunctiva, excessive tearing, swelling of the eyelids and pain. Smoking, male gender and old age are...
4.
Wolthuis D, de Mare S, Verhave J
Eur J Intern Med . 2020 Jan; 72:94-95. PMID: 31901296
No abstract available.
5.
Duineveld C, Verhave J, Berger S, van de Kar N, Wetzels J
Am J Kidney Dis . 2017 Aug; 70(6):770-777. PMID: 28821363
Background: The development of complement inhibitors has greatly improved the outcome of patients with atypical hemolytic uremic syndrome (aHUS), making kidney transplantation a more feasible option. Although prophylactic eculizumab therapy...
6.
Kemps M, Verhave J, Claassen M, Ruinemans-Koerts J, Spek E
Kidney Int . 2017 Jul; 92(3):775-776. PMID: 28697906
No abstract available.
7.
van den Brand J, Verhave J, Adang E, Wetzels J
Nephrol Dial Transplant . 2017 Apr; 32(suppl_1):i115-i122. PMID: 28391343
Background: Kidney transplantation in patients with atypical haemolytic uraemic syndrome (aHUS) is frequently complicated by recurrence of aHUS, often resulting in graft loss. Eculizumab prophylaxis prevents recurrence, improving graft survival....
8.
Haas M, Verhave J, Liu Z, Alpers C, Barratt J, Becker J, et al.
J Am Soc Nephrol . 2016 Sep; 28(2):691-701. PMID: 27612994
The Oxford Classification of IgA nephropathy does not account for glomerular crescents. However, studies that reported no independent predictive role of crescents on renal outcomes excluded individuals with severe renal...
9.
van Beek A, Verhave J
Kidney Int . 2016 Mar; 89(4):958. PMID: 26994578
No abstract available.
10.
Feehally J, Coppo R, Troyanov S, Bellur S, Cattran D, Cook T, et al.
Nephron . 2015 Nov; 132(1):15-24. PMID: 26586175
Background: Tonsillectomy has been considered a treatment for IgA nephropathy (IgAN). It is aimed at removing a source of pathogens, reducing mucosa-associated lymphoid tissue and decreasing polymeric IgA synthesis. However,...